Chapter title |
Cost-Effectiveness Methods and Newborn Screening Assessment
|
---|---|
Chapter number | 16 |
Book title |
Rare Diseases Epidemiology: Update and Overview
|
Published in |
Advances in experimental medicine and biology, January 2017
|
DOI | 10.1007/978-3-319-67144-4_16 |
Pubmed ID | |
Book ISBNs |
978-3-31-967142-0, 978-3-31-967144-4
|
Authors |
I. Castilla-Rodríguez, L. Vallejo-Torres, M. L. Couce, C. Valcárcel-Nazco, J. Mar, P. Serrano-Aguilar |
Abstract |
Nowadays, health funding decisions must be supported by sound arguments in terms of both effectiveness and economic criteria. After more than half a century of newborn screening for rare diseases, the appropriate economic evaluation framework for these interventions is still challenging. The validity of standard methods for economic evaluation heavily relies on the availability of robust evidence, but collection of such evidence is precluded by the rareness of the conditions that may benefit from screening. Furthermore, there are a series of conceptual and methodological limitations that warrant further careful consideration when assessing the cost-effectiveness of newborn screening programs. In this chapter we provide a general overview of current economic evaluation methods and the challenges for their application to newborn screening programs. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 52 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 9 | 17% |
Student > Ph. D. Student | 8 | 15% |
Student > Master | 5 | 10% |
Student > Bachelor | 5 | 10% |
Other | 3 | 6% |
Other | 11 | 21% |
Unknown | 11 | 21% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 25% |
Economics, Econometrics and Finance | 5 | 10% |
Unspecified | 3 | 6% |
Social Sciences | 3 | 6% |
Nursing and Health Professions | 3 | 6% |
Other | 11 | 21% |
Unknown | 14 | 27% |